Aripiprazole and Monocyte count increased - a phase IV clinical study of FDA data
Summary:
Monocyte count increased is reported as a side effect among people who take Aripiprazole (aripiprazole), especially for people who are female, 30-39 old, have been taking the drug for 1 - 2 years also take Clozaril, and have Schizophrenia.
The phase IV clinical study analyzes which people have Monocyte count increased when taking Aripiprazole. It is created by eHealthMe based on reports of 38,853 people who have side effects when taking Aripiprazole from the FDA, and is updated regularly.
What is Aripiprazole?
Aripiprazole has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 39,143 Aripiprazole users. Check the latest studies of Aripiprazole.
What is Monocyte count increased?
Monocyte count increased is found to be associated with 604 drugs and 689 conditions by eHealthMe. Check the latest studies of Monocyte count increased.
38,853 people reported to have side effects when taking Aripiprazole.
Among them, 146 people (0.38%) have Monocyte count increased.
Among these 146 people:
How long have people been on Aripiprazole when they have Monocyte count increased? *
What is the gender of people who have Monocyte count increased when taking Aripiprazole? *
What is the age of people who have Monocyte count increased when taking Aripiprazole? *
What are other drugs people take besides Aripiprazole? *
What are other side effects people have besides Monocyte count increased? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Aripiprazole and have Monocyte count increased?
- Check whether Monocyte count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Aripiprazole:
- Aripiprazole (39,143 reports)
Monocyte count increased treatments and more:
- Monocyte count increased (5,160 reports)
How severe was Monocyte count increased and when was it recovered:
Expand to all the drugs that have ingredients of aripiprazole:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Aripiprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Monocyte count increased:
- Monocyte count increased (604 drugs)
Browse all the conditions that are associated with Monocyte count increased:
- Monocyte count increased (689 conditions)
Related publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Aripiprazole) and Aripiprazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Amoxicillin And Clavulanate Potassium and Celebrex - 4 seconds ago
- Drug interactions of Lorazepam and Cysteine - 5 seconds ago
- Could Cyanocobalamin cause Exercise Tolerance Decreased? - 7 seconds ago
- Could Rythmol cause Blood Phosphorus Increased? - 12 seconds ago
- Could Moxifloxacin Hydrochloride cause Thrombocytopenia? - 12 seconds ago
- Drug interactions of Metronidazole and Elidel - 16 seconds ago
- Could Maxolon cause Intestinal Obstruction? - 17 seconds ago
- Could Maxipime cause Mental Status Changes? - 19 seconds ago
- Drug interactions of Metrogel and Coenzyme Q10 - 21 seconds ago
- Drug interactions of Patanase and Sumatriptan - 22 seconds ago